
Please use this identifier to cite or link to this item:
http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/13398
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Taliyan, Rajeev | - |
dc.date.accessioned | 2023-12-13T08:57:30Z | - |
dc.date.available | 2023-12-13T08:57:30Z | - |
dc.date.issued | 2016 | - |
dc.identifier.uri | https://www.ijp-online.com/article.asp?issn=0253-7613;year=2016;volume=48;issue=1;spage=59;epage=63;aulast=Mittal | - |
dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13398 | - |
dc.description.abstract | The signaling pathways upstream of glycogen synthase kinase-3β (GSK-3β) get reduced during ischemic preconditioning (IPC) in hyperlipidemic rat heart. Pioglitazone, an insulin sensitizer, exerts cardioprotection through GSK-3β. The objective of the study is to investigate the role of pioglitazone on the attenuated cardioprotective effect of IPC in hyperlipidemic rat heart. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Medknow | en_US |
dc.subject | Pharmacy | en_US |
dc.subject | Creatinine kinase | en_US |
dc.subject | Glycogen synthase kinase-3β | en_US |
dc.subject | Ischemia-reperfusion | en_US |
dc.subject | Lactate dehydrogenase | en_US |
dc.subject | Myocardial injury | en_US |
dc.subject | Pioglitazone | en_US |
dc.subject | Rapamycin | en_US |
dc.subject | Wortmannin | en_US |
dc.title | Effect of pioglitazone on the abrogated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart | en_US |
dc.type | Article | en_US |
Appears in Collections: | Department of Pharmacy |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.